Richard S. Chung, MD

Articles by Richard S. Chung, MD

The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes

ByJudy Y. Chen, MD, MSHS,Haijun Tian, PhD,Deborah Taira Juarez, ScD,Krista A. Hodges, MPH, MBA,Jennifer C. Brand, MPH,Richard S. Chung, MD,Antonio P. Legorreta, MD, MPH

January 1st 2010

A pay-for-performance program in a preferred provider organization setting may significantly increase the receipt of quality care and decrease hospitalization rates among patients with diabetes.

Follow-up Services After an Emergency Department Visit for Substance Abuse

ByAndrew R. Breton, MA,Deborah A. Taira, ScD,Eric Burns, MBA,James O'Leary, PhD,Richard S. Chung, MD

September 1st 2007

Copayment Level and Compliance With Antihypertensive Medication: Analysis and Policy Implications for Managed Care

ByDeborah A. Taira, ScD,Ken S. Wong, PharmD,Feride Frech-Tamas, MPH, RPh,Richard S. Chung, MD

November 1st 2006

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

ByDeborah A. Taira, ScD,Kimberly A. Iwane, BS,Richard S. Chung, MD

April 1st 2003

Richard S. Chung, MD

Articles by Richard S. Chung, MD

The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes

Follow-up Services After an Emergency Department Visit for Substance Abuse

Copayment Level and Compliance With Antihypertensive Medication: Analysis and Policy Implications for Managed Care

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Richard S. Chung, MD

Articles by Richard S. Chung, MD

The Effect of a PPO Pay-for-Performance Program on Patients With Diabetes

Follow-up Services After an Emergency Department Visit for Substance Abuse

Copayment Level and Compliance With Antihypertensive Medication: Analysis and Policy Implications for Managed Care

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC